Halogenated	halogenated	O	O	O	O
anesthetics	anesthetics	O	O	O	O
form	form	O	O	O	O
liver	liver	O	O	O	O
adducts	adducts	O	O	O	O
and	and	O	O	O	O
antigens	antigens	O	O	O	O
that	that	O	O	O	O
cross-react	cross-react	O	O	O	O
with	with	O	O	O	O
halothane-induced	halothane-induced	O	O	O	O
antibodies	antibodies	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
halogenated	halogenated	O	O	O	O
anesthetics	anesthetics	O	O	O	O
,	,	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
allergic-type	allergic-type	O	O	O	O
hepatic	hepatic	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
both	both	O	O	O	O
alone	alone	O	O	O	O
and	and	O	O	O	O
following	following	O	O	O	O
previous	previous	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
halothane	halothane	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Halothane	halothane	CHEMICALS	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
appears	appears	O	O	O	O
to	to	O	O	O	O
involve	involve	O	O	O	O
an	an	O	O	O	O
aberrant	aberrant	O	O	O	O
immune	immune	O	O	O	O
response	response	O	O	O	O
.	.	O	O	O	O

An	an	O	O	O	O
antibody	antibody	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
protein-bound	protein-bound	O	O	O	O
biotransformation	biotransformation	O	O	O	O
product	product	O	O	O	O
(	(	O	O	O	O
trifluoroacetyl	trifluoroacetyl	O	O	OTHERS	I
adduct	adduct	O	O	O	O
)	)	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
detected	detected	O	O	O	O
on	on	O	O	O	O
halothane	halothane	CHEMICALS	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
performed	performed	O	O	O	O
to	to	O	O	O	O
determine	determine	O	O	O	O
cross-reactivity	cross-reactivity	O	O	O	O
between	between	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
the	the	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
halothane	halothane	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
subcellular	subcellular	O	O	O	O
and	and	O	O	O	O
lobular	lobular	O	O	O	O
production	production	O	O	O	O
of	of	O	O	O	O
hepatic	hepatic	O	O	O	O
neoantigens	neoantigens	O	O	O	O
recognized	recognized	O	O	O	O
by	by	O	O	O	O
halothane-induced	halothane-induced	O	O	O	O
antibodies	antibodies	O	O	O	O
following	following	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
biochemical	biochemical	O	O	O	O
nature	nature	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
neoantigens	neoantigens	O	O	O	O
was	was	O	O	O	O
investigated	investigated	O	O	O	O
in	in	O	O	O	O
two	two	O	O	O	O
animal	animal	O	O	O	O
models	models	O	O	O	O
.	.	O	O	O	O

Enflurane	enflurane	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
neoantigens	neoantigens	O	O	O	O
detected	detected	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
the	the	O	O	O	O
microsomal	microsomal	O	O	O	O
and	and	O	O	O	O
cytosolic	cytosolic	O	O	O	O
fraction	fraction	O	O	O	O
of	of	O	O	O	O
liver	liver	O	O	O	O
homogenates	homogenates	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
centrilobular	centrilobular	O	O	O	O
region	region	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
liver	liver	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
liver	liver	O	O	O	O
,	,	O	O	O	O
biochemical	biochemical	O	O	O	O
analysis	analysis	O	O	O	O
detected	detected	O	O	O	O
fluorinated	fluorinated	O	O	O	O
liver	liver	O	O	O	O
adducts	adducts	O	O	O	O
that	that	O	O	O	O
were	were	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
20-fold	20-fold	O	O	O	O
greater	greater	O	O	O	O
in	in	O	O	O	O
guinea	guinea	O	O	O	O
pigs	pigs	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
supports	supports	O	O	O	O
and	and	O	O	O	O
extends	extends	O	O	O	O
previous	previous	O	O	O	O
evidence	evidence	O	O	O	O
for	for	O	O	O	O
a	a	O	O	O	O
mechanism	mechanism	O	O	O	O
by	by	O	O	O	O
which	which	O	O	O	O
enflurane	enflurane	CHEMICALS	O	OTHERS	I
and/or	and/or	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
could	could	O	O	O	O
produce	produce	O	O	O	O
a	a	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
condition	condition	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
halothane	halothane	CHEMICALS	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
either	either	O	O	O	O
alone	alone	O	O	O	O
or	or	O	O	O	O
subsequent	subsequent	O	O	O	O
to	to	O	O	O	O
halothane	halothane	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
guinea	guinea	O	O	O	O
pig	pig	O	O	O	O
would	would	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
useful	useful	O	O	O	O
model	model	O	O	O	O
for	for	O	O	O	O
further	further	O	O	O	O
investigations	investigations	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
immunological	immunological	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
these	these	O	O	O	O
antigens	antigens	O	O	O	O
.	.	O	O	O	O

